Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
Tóm tắt
Từ khóa
Tài liệu tham khảo
Batchelor, 2007, AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients, Cancer Cell, 11, 83, 10.1016/j.ccr.2006.11.021
Bendell, 2003, Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma, Cancer, 97, 2972, 10.1002/cncr.11436
Berger, 1999
Bergers, 2008, Modes of resistance to anti-angiogenic therapy, Nat. Rev. Cancer, 8, 592, 10.1038/nrc2442
Bergers, 2003, Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors, J. Clin. Invest., 111, 1287, 10.1172/JCI200317929
Blouw, 2003, The hypoxic response of tumors is dependent on their microenvironment, Cancer Cell, 4, 133, 10.1016/S1535-6108(03)00194-6
Blouw, 2007, Loss of vascular endothelial growth factor expression reduces vascularization, but not growth, of tumors lacking the Von Hippel-Lindau tumor suppressor gene, Oncogene, 26, 4531, 10.1038/sj.onc.1210249
Cairns, 2001, Acute (cyclic) hypoxia enhances spontaneous metastasis of KHT murine tumors, Cancer Res., 61, 8903
Casanovas, 2005, Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors, Cancer Cell, 8, 299, 10.1016/j.ccr.2005.09.005
Clayton, 2004, Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer, Br. J. Cancer, 91, 639, 10.1038/sj.bjc.6601970
Du, 2008, HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion, Cancer Cell, 13, 206, 10.1016/j.ccr.2008.01.034
Ebos, 2009, Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis, Cancer Cell, 15, 232, 10.1016/j.ccr.2009.01.021
Faivre, 2007, Molecular basis for sunitinib efficacy and future clinical development, Nat. Rev. Drug Discov., 6, 734, 10.1038/nrd2380
Fischer, 2008, High-grade glioma before and after treatment with radiation and Avastin: initial observations, Neuro-oncol., 10, 700, 10.1215/15228517-2008-042
Folkman, 1971, Tumor angiogenesis: therapeutic implications, N. Engl. J. Med., 285, 1182, 10.1056/NEJM197111182852108
Folkman, 2007, Angiogenesis: an organizing principle for drug discovery?, Nat. Rev. Drug Discov., 6, 273, 10.1038/nrd2115
Folkman, 1992, Inhibition of angiogenesis, Semin. Cancer Biol., 3, 89
Gomez-Manzano, 2008, VEGF Trap induces antiglioma effect at different stages of disease, Neuro Oncol., 10, 940, 10.1215/15228517-2008-061
Hanahan, 1985, Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes, Nature, 315, 115, 10.1038/315115a0
Hanahan, 1996, Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis, Cell, 86, 353, 10.1016/S0092-8674(00)80108-7
Higgins, 2007, Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition, J. Clin. Invest., 117, 3810
Inoue, 2002, VEGF-A has a critical, nonredundant role in angiogenic switching and pancreatic beta cell carcinogenesis, Cancer Cell, 1, 193, 10.1016/S1535-6108(02)00031-4
Kerbel, 2000, Tumor angiogenesis: past, present and the near future, Carcinogenesis, 21, 505, 10.1093/carcin/21.3.505
Kerbel, 2001, Possible mechanisms of acquired resistance to anti-angiogenic drugs: implications for the use of combination therapy approaches, Cancer Metastasis Rev., 20, 79, 10.1023/A:1013172910858
Kunkel, 2001, Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2, Cancer Res., 61, 6624
Lopez, 2002, Elevated levels of IGF-1 receptor convey invasive and metastatic capability in a mouse model of pancreatic islet tumorigenesis, Cancer Cell, 1, 339, 10.1016/S1535-6108(02)00055-7
Miller, 2003, Occult central nervous system involvement in patients with metastatic breast cancer: prevalence, predictive factors and impact on overall survival, Ann. Oncol., 14, 1072, 10.1093/annonc/mdg300
Miller, 2005, Can tumor angiogenesis be inhibited without resistance?, EXS, 94, 95
Munoz-Najar, 2006, Hypoxia stimulates breast carcinoma cell invasion through MT1-MMP and MMP-2 activation, Oncogene, 25, 2379, 10.1038/sj.onc.1209273
Narayana, 2009, Antiangiogenic therapy using bevacizumab in recurrent high-grade glioma: impact on local control and patient survival, J. Neurosurg., 110, 173, 10.3171/2008.4.17492
Norden, 2008, Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence, Neurology, 70, 779, 10.1212/01.wnl.0000304121.57857.38
Offerhaus, 1991, The value of immunohistochemistry for collagen IV expression in colorectal carcinomas, Cancer, 67, 99, 10.1002/1097-0142(19910101)67:1<99::AID-CNCR2820670119>3.0.CO;2-K
Parangi, 1996, Antiangiogenic therapy of transgenic mice impairs de novo tumor growth, Proc. Natl. Acad. Sci. USA, 93, 2002, 10.1073/pnas.93.5.2002
Pennacchietti, 2003, Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene, Cancer Cell, 3, 347, 10.1016/S1535-6108(03)00085-0
Pietras, 2005, A multitargeted, metronomic, and maximum-tolerated dose “chemo-switch” regimen is antiangiogenic, producing objective responses and survival benefit in a mouse model of cancer, J. Clin. Oncol., 23, 939, 10.1200/JCO.2005.07.093
Roskoski, 2007, Sunitinib: a VEGF and PDGF receptor protein kinase and angiogenesis inhibitor, Biochem. Biophys. Res. Commun., 356, 323, 10.1016/j.bbrc.2007.02.156
Rubenstein, 2000, Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption, Neoplasia, 2, 306, 10.1038/sj.neo.7900102
Shaked, 2005, Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis; Implications for cellular surrogate marker analysis of antiangiogenesis, Cancer Cell, 7, 101
Skobe, 1997, Halting angiogenesis suppresses carcinoma cell invasion, Nat. Med., 3, 1222, 10.1038/nm1197-1222
Warren, 1995, Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis, J. Clin. Invest., 95, 1789, 10.1172/JCI117857
Weil, 2005, Breast cancer metastasis to the central nervous system, Am. J. Pathol., 167, 913, 10.1016/S0002-9440(10)61180-7